The Clinical Unmet need in the patient with Diabetes and ACS

The Clinical Unmet need in the patient with Diabetes and ACS
10' education - Aug. 26, 2017 - Barcelona, Spain - Kausik Ray, MD Imperial College London United Kingdom - PACE-CME symposium held at ESC 2017 - Online CME
  • Overview

    This lecture was part of a CME accredited symposium: 'Managing Diabetes & CVD: Is epigenetics a new way forward?' held at ESC 2017 in Barcelona on August 26, 2017

  • Educational information

    The educational objectives of this symposium were to:

    • To summarise the epidemiology and pathophysiology of patients at high cardiovascular risk with diabetes
    • To understand the origin of the high residual cardiovascular risk in patients with diabetes, ACS
    • To review how BET inhibition affects gene expression via epigenetic mechanisms, as a novel strategy to improve outcomes in CVD
    • To update and review current clinical research programmes evaluating the role of epigenetic regulation of gene expression in CVD management
  • Disclosures

    Kausik Ray, MD, is cardiologist, and Professor of Public Health/Honorary Consultant Cardiologist at Imperial College London, United Kingdom

  • Funding

    This symposum was supported by an unrestricted educational grant provided by Resverlogix

    The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Facebook Comments


We’re glad to see you’re enjoying PACE-CME…
but how about a more personalized experience?

Register for free